Search - tctmd.com

Displaying 401 - 420 of 468

Sort: Relevancy | Date

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Daily News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

Caitlin E. Cox

April 03, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Shelley Wood

April 02, 2020

News Conference News ACC 2020

E-Cigarettes Added to Counseling Can Help Smokers Quit at 12 Weeks

Caitlin E. Cox

March 31, 2020

News Daily News

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Yael L. Maxwell

March 26, 2020

News Daily News

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

L.A. McKeown

March 25, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Daily News

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Michael O'Riordan

February 21, 2020

News Daily News

Nearly Half of Diabetic Patients Struggle to Pay Medical Bills

Michael O'Riordan

February 12, 2020

News Daily News

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Michael O'Riordan

February 06, 2020

News Daily News

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Yael L. Maxwell

January 28, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use

L.A. McKeown

January 21, 2020

News Daily News

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

L.A. McKeown

January 17, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

Yael L. Maxwell

December 26, 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Advertisement

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

COVID-19 Drug Candidates May Raise Arrhythmia Risk

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

E-Cigarettes Added to Counseling Can Help Smokers Quit at 12 Weeks

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

Inclisiran Data in NEJM Prompt Talk of What Comes Next

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Nearly Half of Diabetic Patients Struggle to Pay Medical Bills

Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content